Cargando…
The tumor suppressor activity of DLC1 requires the interaction of its START domain with Phosphatidylserine, PLCD1, and Caveolin-1
BACKGROUND: DLC1, a tumor suppressor gene that is downregulated in many cancer types by genetic and nongenetic mechanisms, encodes a protein whose RhoGAP and scaffolding activities contribute to its tumor suppressor functions. The role of the DLC1 START (StAR-related lipid transfer; DLC1-START) doma...
Autores principales: | Sanchez-Solana, Beatriz, Wang, Dunrui, Qian, Xiaolan, Velayoudame, Parthibane, Simanshu, Dhirendra K., Acharya, Jairaj K., Lowy, Douglas R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561924/ https://www.ncbi.nlm.nih.gov/pubmed/34727930 http://dx.doi.org/10.1186/s12943-021-01439-y |
Ejemplares similares
-
CDK5 is a major regulator of the tumor suppressor DLC1
por: Tripathi, Brajendra K., et al.
Publicado: (2014) -
DLC1 is the principal biologically-relevant down-regulated DLC family member in several cancers
por: Wang, Dunrui, et al.
Publicado: (2016) -
SRC and ERK cooperatively phosphorylate DLC1 and attenuate its Rho-GAP and tumor suppressor functions
por: Tripathi, Brajendra K., et al.
Publicado: (2019) -
DLC1: a tumor suppressor that regulates Rho signaling
por: Tripathi, Brajendra K., et al.
Publicado: (2017) -
Inhibition of cytoplasmic EZH2 induces antitumor activity through stabilization of the DLC1 tumor suppressor protein
por: Tripathi, Brajendra K., et al.
Publicado: (2021)